This is a match-making section for JPIAMR 14th call - Disrupting drug Resistance Using Innovative Design (DRUID).
Human Health Animal Health (including wild-life, livestock, fishes, and companion animals) Plants (including trees and crops)
in silico, in vitro, in vivo
structural biology; drug development; structure-activity-relationships; efficacy; specificity
Our lab specializes in structure-function studies of antibacterial and antifungal drug targets, as well as resistance determinants i.e. antibiotic-modifying enzymes. We participate in the Center for Structural Genomics of Infectious Diseases (CSGID), funded by the National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) USA. We have determined more than 200 crystal structures and are one of the most pre-eminent centers for structural biology of AMR. We have more than 40+ years of expertise in: -protein purification -protein crystallization -cryo-EM -protein 3D structure determination and analysis -drug + drug target complex structure determination and analysis -structure-activity-relationships -in vitro activity assay development -3D structure modeling -docking, virtual screening -antimicrobial susceptibility testing (AST)
We have deep expertise in particular drug classes including but not limited to: aminoglycosides, macrolides, streptogramins, glycopeptides, lincosamides and sulfonamides. We are looking to join a consortium to improve the efficacy and/or specificity of antimicrobials and can contribute the above expertise to your project.
Submitted on 2022-01-25 17:29:02
« Return to the partner search tool